In a major boost to cardiovascular research, the National Institutes of Health has awarded an additional $3.7 million to Shengyu Mu, PhD, and his team of researchers at the University of Arkansas for Medical Sciences (UAMS) to continue their groundbreaking study on the role of immune cells in hypertension.
Mu, an associate professor in the UAMS College of Medicine Department of Pharmacology and Toxicology, was awarded an initial $1.89 million grant in 2019 to fund his laboratory’s exploration of the link between immune cells and hypertension, a widespread and serious health condition.
During that time, the team made substantial discoveries indicating that immune disorders contribute to high blood pressure, paving the way for the next phase of research.
The five-year grant renewal began with a $685,749 payment in April and is expected to fund a comprehensive series of experiments and advanced analyses over the next five years.
“We are thrilled to receive this continued support from the NIH,” said Mu, a leading expert in hypertension. “Our initial research has provided strong evidence that immune cells play a key role in the development and progression of hypertension. This new funding will allow us to delve even deeper, aiming to identify new therapeutic targets and develop novel strategies to manage hypertension.”